cilazapril, anhydrous has been researched along with Nephrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, M; Fujita, T; Hidaka, M; Ohi, H; Ohsawa, I; Satomura, A | 1 |
1 trial(s) available for cilazapril, anhydrous and Nephrosis
| Article | Year |
|---|---|
Angiotensin-converting enzyme inhibitors improve nephrosis more quickly than calcium antagonists in diabetic patients.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cilazapril; Diabetic Nephropathies; Female; Humans; Hypertension, Renal; Male; Middle Aged; Nephrosis; Prospective Studies; Proteinuria; Renal Circulation | 2000 |